Stocks and Crypto Extend Slump, Exclusive With Take-Two CEO on Zynga Deal, and Gilead Sciences CEO on the Battle to Treat COVID

Squawk on the Street - Stocks and Crypto Extend Slump, Exclusive With Take-Two CEO on Zynga Deal, and Gilead Sciences CEO on the Battle to Treat COVID